| __timestamp | Agios Pharmaceuticals, Inc. | Alpine Immune Sciences, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 100371000 | 12199547 |
| Thursday, January 1, 2015 | 141827000 | 16054000 |
| Friday, January 1, 2016 | 220163000 | 23316000 |
| Sunday, January 1, 2017 | 292681000 | 10626000 |
| Monday, January 1, 2018 | 341324000 | 28970000 |
| Tuesday, January 1, 2019 | 410894000 | 35847000 |
| Wednesday, January 1, 2020 | 367470000 | 27185000 |
| Friday, January 1, 2021 | 256973000 | 58742000 |
| Saturday, January 1, 2022 | 279910000 | 70243000 |
| Sunday, January 1, 2023 | 288903000 | 80904000 |
| Monday, January 1, 2024 | 301286000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Agios Pharmaceuticals, Inc. and Alpine Immune Sciences, Inc. have demonstrated contrasting strategies in their R&D investments.
Agios Pharmaceuticals has consistently led the charge, with R&D expenses peaking in 2019 at approximately 41% higher than their 2014 levels. This reflects their aggressive pursuit of groundbreaking therapies. In contrast, Alpine Immune Sciences, while starting from a smaller base, has shown a remarkable growth trajectory, with their R&D spending increasing by over 560% from 2014 to 2023.
These trends highlight the dynamic nature of the biotech industry, where strategic investments in R&D can pave the way for future breakthroughs and market leadership.
Comparing Innovation Spending: BeiGene, Ltd. and Alpine Immune Sciences, Inc.
R&D Insights: How Intra-Cellular Therapies, Inc. and Alpine Immune Sciences, Inc. Allocate Funds
Research and Development Expenses Breakdown: Bio-Techne Corporation vs Alpine Immune Sciences, Inc.
Comparing Innovation Spending: Ascendis Pharma A/S and Agios Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Alpine Immune Sciences, Inc.
Analyzing R&D Budgets: Grifols, S.A. vs Agios Pharmaceuticals, Inc.
Analyzing R&D Budgets: Corcept Therapeutics Incorporated vs Agios Pharmaceuticals, Inc.
Research and Development Investment: Alpine Immune Sciences, Inc. vs ImmunityBio, Inc.
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Galapagos NV
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Xencor, Inc.
Research and Development Expenses Breakdown: Agios Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.